1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 TOP-DOWN APPROACH
2.2 BOTTOM-UP APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOPHARMACEUTICAL  MARKET SNAPSHOT
3.2 GLOBAL BIOPHARMACEUTICAL  MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL BIOPHARMACEUTICAL , BY  PRODUCT TYPE
5.1 OVERVIEW
5.2 TESTOSTERONE GEL
5.3 BIOTECH VACCINES
5.4 HUMAN GROWTH HORMONES
5.5 PURIFIED PROTEINS
5.6 OTHERS
6 GLOBAL BIOPHARMACEUTICAL , BY THERAPEUTIC AREAS
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 NEWROLOGY
6.4 CARDIOVASCULAR
6.5 DIABETES
6.6 OTHERS THERAPEUTIC AREA
7 GLOBAL BIOPHARMACEUTICAL MARKET, BY END-USER
7.1 RESEARCH CENTER
7.2 PHARMACEUTICAL SECTOR
7.3 HEALTH CARE INDUSTRY
8 GLOBAL BIOPHARMACEUTICAL  MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 DRIVERS
8.1.1.2 RESTRAINTS
8.1.1.3 OPPORTUNITY
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 DRIVERS
8.2.1.2 RESTRAINTS
8.2.1.3 OPPORTUNITY
8.2.2 U.K.
8.2.3 FRANCE
8.2.4 GERMANY
8.2.5 SPAIN
8.2.6 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 DRIVERS
8.3.1.2 RESTRAINTS
8.3.1.3 OPPORTUNITY
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 DRIVERS
8.4.1.2 RESTRAINTS
8.4.1.3 OPPORTUNITY
8.4.2 SOUTH AFRICA
8.4.3 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 DRIVERS
8.5.1.2 RESTRAINTS
8.5.1.3 OPPORTUNITY
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 GLOBAL BIOPHARMACEUTICAL  MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 LG LIFE SCIENCE
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 PFIZER
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 JOHNSON& JOHNSON
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 ROCHE HOLDING AG
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 BIOCON LTD
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7  RANBAXY LABORATORIES LTD
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 GLAXOSMITHKLINE
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS